Clinical trial
Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast…
NCT00002646 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002646 |
|---|---|
| Title | Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer |
| Official title | PHASE III DOUBLE-BLIND, PLACEBO-CONTROLLED, PROSPECTIVE RANDOMIZED COMPARISON OF ADJUVANT THERAPY WITH TAMOXIFEN VS. TAMOXIFEN AND FENRETINIDE IN POSTMENOPAUSAL WOMEN WITH INVOLVED AXILLARY LYMPH NODES AND POSITIVE RECEPTORS |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH SWOG Cancer Research Network Cancer and Leukemia Group B North Central Cancer Treatment Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | fenretinide, tamoxifen citrate |
| Enrollment | 1,500 |
| Start date | Oct 1, 1995 |
| Primary completion | Feb 1, 2004 |
| First posted | Jun 10, 2004 |
| Last update posted | Jan 5, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: